Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
DR-10627 by Zhejiang Doer Biologics for Diabetes: Likelihood of Approval
DR-10627 is under clinical development by Zhejiang Doer Biologics and currently in Phase I for Diabetes. According to GlobalData, Phase...
Data Insights
DR-10627 by Zhejiang Doer Biologics for Metabolic Dysfunction-Associated Steatohepatitis (MASH): Likelihood of Approval
DR-10627 is under clinical development by Zhejiang Doer Biologics and currently in Phase I for Metabolic Dysfunction-Associated Steatohepatitis (MASH). According...